Background Glioblastoma multiforme (GBM) is extensively genetically and transcriptionally
heterogeneous, which poses challenges for classification and management. Long …

Background: A variety of regulatory approaches including immune modulation have been
explored as approaches to either eradicate antitumor response or induce suppressive …

Background The tumor immune microenvironment is closely related to the malignant
progression and treatment resistance of glioma. Long non-coding RNA (lncRNA) plays a …

Glioma is the most common and fatal primary brain tumor in human. Long non-coding RNA
(lncRNA), which are characterized by regulation of gene expression and chromatin …

Background Glioblastoma multiforme (GBM) is the most common primary malignant brain
tumor in adults. This study aimed to construct immune-related long non-coding RNAs …

Glioma is the most commonly occurring primary neuroepithelial neoplasm. Long noncoding
RNAs (lncRNAs) are emerging as pivotal modulators of gene expression in the immune …

Glioblastoma multiforme (GBM) is the most aggressive primary tumor of the central nervous
system. As biomedicine advances, the researcher has found the development of GBM is …

Long noncoding ribonucleic acids (RNAs; lncRNAs) have been associated with cancer
immunity regulation. However, the roles of immune cell-specific lncRNAs in glioblastoma …

Rationale: Accumulating evidence demonstrated that long noncoding RNAs (lncRNAs)
involved in the regulation of the immune system and displayed a cell-type-specific pattern in …

Background The prognostic value of immune-related genes and lncRNAs in neuroblastoma
has not been elucidated, especially in subgroups with different outcomes. This study aimed …